Cardinal Health Agrees to Disbribute Generex Biotechnology Product
Generex Biotechnology reports that Cardinal Health will distribute its new Glucose RapidSpray™ product in the U.S.
The product is an alternative for people who require or want additional glucose in their diet, notes a Generex Biotechnology spokesperson, who adds that Glucose RapidSpray delivers a fat-free, low-calorie glucose formulation that was developed using the company’s buccal drug delivery technologies. Glucose RapidSpray delivers glucose directly into the mouth where the formulation is rapidly absorbed into the blood stream, explains Anna Gluskin, president and CEO of Generex.
“Using our patented RapidMist™ technology, we’ve developed a product that will deliver glucose to anyone who needs a fast and efficient means for receiving glucose,” she continues. “We expect that Glucose RapidSpray will appeal to people battling the symptoms of low blood sugar who now use other over-the-counter glucose products but want a faster-acting product. We expect to position Glucose RapidSpray as a companion product to Generex Oral-lyn™, our proprietary oral insulin spray product, in the diabetes management field.”>